Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: a year ago

Possible Interaction: Cannabinoids and Dopamine

supplement:

Cannabinoids

Research Papers that Mention the Interaction

Owing to the complexity of the cannabinoid– dopamine interactions that take place, there is conflicting evidence from human and animal studies concerning the effects of THC on the dopamine system.
Nature  •  2016  |  View Paper
Numerous animal studies show that administering exogenous cannabinoids alters the balance of excitation and inhibition reaching dopamine cells , most frequently causing an increase in firing with attendant elevations of dopamine release at downstream forebrain territories.
Biological Psychiatry  •  2014  |  View Paper
For example, there is general agreement that cannabinoids suppress dopamine release and presynaptically reduce transmitter release from cones and bipolar cells.
Progress in Retinal and Eye Research  •  2008  |  View Paper
We can assume that endogenous cannabinoids serve to modulate dopamine neurotransmission and that these effects may differ depending upon the state of activation of the dopamine circuits.
British journal of pharmacology  •  2002  |  View Paper
Recent animal data demonstrate complex interactions between dopamine and cannabinoid type 1 signaling , a potential mechanism for haloperidol success in patients with CHS.
American journal of therapeutics  •  2017  |  View Paper
Although the exact mechanism for CHS remains unclear, animal data demonstrate complex interactions between dopamine and cannabinoid type 1 signaling , a potential mechanism for haloperidol success in patients with CHS, and the reason why we started using it [6].
Journal of Medical Toxicology  •  2017  |  View Paper
Dopamine and endogenous opioids are among the neurotransmitters that result more affected by perinatal cannabinoid exposure, which, when animals mature, produce changes in motor activity, drug-seeking behavior, nociception and other processes.
Neurotoxicity Research  •  2009  |  View Paper
Endogenous cannabinoids appear to modulate transmitter systems (e.g. dopamine ) within the basal ganglia.
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology  •  2004  |  View Paper
Cannabinoids also increase dopamine release within the mesolimbic system, a neural pathway generally implicated in timing behavior.
In the present study, we hypothesized that cannabinoids would accelerate timing behavior in an FI task while concurrently augmenting a temporally relevant pattern of dopamine release.
To date, it remains unknown how cannabinoids modulate dopamine release when responding under FI conditions, and for that matter, how subsecond dopamine release is related to time in these tasks.
Neuropsychopharmacology  •  2014  |  View Paper
These measures add opioids to the growing list of abused drugs (including ethanol, nicotine, cocaine and cannabinoids ) that elicit rapid surges in NAc dopamine concentrations.
The European journal of neuroscience  •  2014  |  View Paper
Show More